from Dreamers to Disruptors

This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors , a podcast by Medidata.

from Dreamers to Disruptors is a health podcast hosted by Unknown Host, with 15 episodes on record and a Required Pod Score of 80.

Unknown Host hosts from Dreamers to Disruptors, a health show with 15 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  from Dreamers to Disruptors

  Bayesian Health’s Dr. Suchi Saria on Accelerating AI Adoption and Fighting Sepsis

  Sep 21, 20261h 9m

  AI tools are saving lives. With a level of pattern recognition that no human could ever hope to match, they can identify the hidden signs that indicate life-threatening complications, and empower healthcare professionals to take action before things escalate. But a tool is only effective if it’s put to use, and in many cases adoption is slow and far from widespread. Bayesian Health CEO and Co-Founder Dr. Suchi Saria is accelerating the process, drawing on her experiences at Johns Hopkins to develop AI-powered solutions that have become deeply embedded in the day-to-day practices of major healthcare institutions. She joins Medidata CEO Anthony Costello for a wide-ranging conversation that explores Bayesian’s human-machine teaming approach to developing new technologies, and the future of interconnected health data that is just on the horizon. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Suchi: LinkedIn

  ListenShow Notes
• 

  from Dreamers to Disruptors

  Man Up to Cancer’s Trevor Maxwell on Building Communities and Empowering Patients

  Aug 10, 202641 min

  A cancer diagnosis is one of the most challenging experiences a person can have. As well as the physical consequences of serious illness, people can find themselves feeling isolated as they struggle with fear and uncertainty about what lies ahead. By founding Man Up to Cancer, Trevor Maxwell is giving people the confidence and community they need to confront diagnosis, treatment, and the day-to-day reality of living with the disease. He joins Medidata’s Chief Patient Officer Alicia Staley to share his experience with colon cancer, and his amazing journey to become a patient advocate. They explore the problems of toxic positivity and lack of motivation, the relationship between clinical research and cancer communities, and how to use your skills and knowledge to make a positive difference for yourself and those around you. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Alicia: LinkedIn Follow Trevor: LinkedIn

  ListenShow Notes
• 

  from Dreamers to Disruptors

  DTRA’s Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research

  Jul 13, 20261h 6m

  New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation. As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies. He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Craig: LinkedIn

  ListenShow Notes
• 

  from Dreamers to Disruptors

  Medidata NEXT London 2026 LIVE

  Jun 23, 202656 min

  At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and life sciences from around the world, they explore industry challenges and share their excitement for what the future holds. That made NEXT Innovation Day London the perfect venue for our latest live edition of from Dreamers to Disruptors . Recorded straight from the show floor, Medidata leaders and a broad range of guests break down the power and incredible potential of AI across the clinical trial process, combining diverse perspectives into a united vision for the next era of healthcare technology. Session 1 Speakers: Edward Ford | Vice President, Client Engagement, Medidata Anthony Costello | CEO, Medidata Nitish Mittal | Partner, Everest Group Krzysztof Wróblewski | Head of Global Clinical Solutions Technologies, Senior Director, AstraZeneca Session 2 Speakers: Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata Lisa Moneymaker | Chief Strategy Officer, Medidata Chris Standley | Vice President, Vendor Governance, Worldwide Clinical Trials Session 3 Speakers: Wayne Walker | GM, Head of Data Experience, Medidata Robyn Orie | Sr. Director, Data Innovation, Caidya Cassie Kendrew | Chief Operating Officer, EMS Healthcare Amardeep Heer | Medidata Site Insights Board Member | Principal Investigator, Lakeside Healthcare Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube

  ListenShow Notes
• 

  from Dreamers to Disruptors

  Fighting Cancer with External Control Arms: Friends of Cancer Research’s Jeff Allen

  May 26, 202639 minS0

  <p>External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients’ lives are on the line. They’re particularly valuable for cancer research, where patients can neither afford to wait nor settle for the current standard of care.</p><p>Friends of Cancer Research President and CEO Jeff Allen sits down with Medidata CEO Anthony Costello and Senior Vice President, Statistics and Regulatory Science Innovation Ruthie Davi to celebrate 30 years of oncology innovation, and explore what’s coming next.</p><p>They dig deep into Medidata and Friend...

  ListenShow Notes

Recent guests on from Dreamers to Disruptors. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.